Bioleaders Corporation (142760) — Capital Reinvestment Ratio
Bioleaders Corporation (142760) has a Capital Reinvestment Ratio of 21.04x as of September 2024, meaning it reinvests 21% of its operating cash flow (₩49.56 Million) in capital expenditures (₩1.04 Billion). Check Bioleaders Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bioleaders Corporation Capital Reinvestment Ratio (2023–2023)
This chart tracks Bioleaders Corporation's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Bioleaders Corporation.
Annual Capital Reinvestment Ratio for Bioleaders Corporation (2023–2023)
Year-by-year Capital Reinvestment Ratio for Bioleaders Corporation from 2023 to 2023. See free cash flow generation of Bioleaders Corporation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | ₩6.18 Billion | ₩378.81 Million | — |